| 000 | 01322 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513150128.0 | ||
| 264 | 0 | _c19981105 | |
| 008 | 199811s 0 0 eng d | ||
| 022 | _a0172-6390 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAnnibale, B | |
| 245 | 0 | 0 |
_aOmeprazole in patients with mild or moderate reflux esophagitis induces lower relapse rates than ranitidine during maintenance treatment. _h[electronic resource] |
| 260 |
_bHepato-gastroenterology _c |
||
| 300 |
_a742-51 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aEsophagitis, Peptic _xdrug therapy |
| 650 | 0 | 4 | _aEvaluation Studies as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOmeprazole _xadverse effects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRanitidine _xadverse effects |
| 650 | 0 | 4 | _aSecondary Prevention |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aFranceschi, M | |
| 700 | 1 | _aFusillo, M | |
| 700 | 1 | _aBeni, M | |
| 700 | 1 | _aCesana, B | |
| 700 | 1 | _aDelle Fave, G | |
| 773 | 0 |
_tHepato-gastroenterology _gvol. 45 _gno. 21 _gp. 742-51 |
|
| 999 |
_c9649863 _d9649863 |
||